Global $70 Billion Regenerative Medicine Market Analysis to 2028 - ResearchAndMarkets.com
Retrieved on:
Tuesday, May 16, 2023
Health, Pharmaceutical, GSK, Amgen, The Global Institute for Tomorrow, COVID-19, Bayer, Medicine, Infection, Food, Takeda Pharmaceutical Company, Cancer, Foreign Affairs, Paratriathlon, Multinational corporation, DSM-IV codes, Prostate, United States Department of Health and Human Services, AstraZeneca, Lung, Stomach, Colon, Regenerative medicine, Ministry, Death, GSK plc, Criticism of the Food and Drug Administration, Rectum, Patent, Patient, Immune system, Voretigene neparvovec, Conditional sentence, Growth, Integra LifeSciences, Region, FDA, Vericel, B cell, Ministry of Economics (Latvia), United Arab Emirates, Skin, World Health Organization, Novartis, Pharmaceutical industry, Vaccine, Video game, Economics, Research
The "Global Regenerative Medicine Market Size, Segments, Outlook, and Revenue Forecast 2022-2028 by Product Type, Material, Application, and Region" report has been added to ResearchAndMarkets.com's offering.
Key Points:
- The "Global Regenerative Medicine Market Size, Segments, Outlook, and Revenue Forecast 2022-2028 by Product Type, Material, Application, and Region" report has been added to ResearchAndMarkets.com's offering.
- The Global Regenerative Medicine Market - which grew from approximately US$ 15 billion in 2017 to approximately US$ 30 billion in 2022 - is forecasted to grow further into approximately US$ 70 billion opportunities by 2028, owing to the growing severe diseases, infections, and cancers.
- Regenerative medicine market is driven by surging trauma cases, genetic disorders, chronic diseases, and other infectious viruses.
- The rising number of cancer patients worldwide is driving the growth of the regenerative medicine market.